Latest Financials News

Neuren Pharmaceuticals has received detailed feedback from the US FDA on its clinical development plans for NNZ-2591 targeting hypoxic ischemic encephalopathy and Pitt Hopkins syndrome, paving a clearer path forward despite some delays.

Evolution Trustees has appointed LDR Capital as the new manager of Elanor Commercial Property Fund following the termination of previous management agreements with Elanor Asset Services.

Garda Property Group reported a 16% rise in revenue and a 20% increase in funds from operations for the first half of 2026, while net profit after tax fell by nearly 24%. The group declared a steady interim distribution of 4 cents per security.

Hot Chili Limited has raised A$40 million through a heavily oversubscribed private placement to accelerate the development of its La Verde copper-gold discovery within the Costa Fuego project in Chile. The funding will support expanded feasibility studies, environmental approvals, and further drilling aimed at defining a higher-grade starter pit.

Livium Ltd announces a further A$335,000 distribution from its 50% stake in the LieNA joint venture, following receipt of a substantial R&D tax incentive rebate for FY25. The joint venture remains well-funded through FY27, supporting ongoing lithium extraction technology development.

Botala Energy has raised A$3 million through an oversubscribed placement to fully fund drilling and flow testing at its Serowe coal bed methane project this quarter, advancing its commercial gas ambitions.

The Federal Court of Australia has approved key restructuring schemes for Global Uranium and Enrichment Limited, paving the way for streamlined shareholder arrangements and regulatory exemptions in multiple jurisdictions.

PYC Therapeutics has successfully closed a $537 million institutional placement and entitlement offer, positioning the company to raise at least $600 million to advance its RNA-based therapies targeting genetic diseases.

Island Pharmaceuticals has raised $9 million to advance its antiviral drug Galidesivir through the FDA’s Animal Rule pathway, targeting inclusion in the US Strategic National Stockpile for biodefense viruses.

Worley Limited has been awarded a reimbursable EPC contract for Phase 2 of the CP2 Project, reinforcing its role in a strategically vital global energy infrastructure initiative.

Bellavista Resources has successfully raised A$35 million through a two-tranche placement to fund its strategic acquisition and exploration plans in Canada and Australia.

Heavy Rare Earths Limited has broadened its mineral rights at the Radium Hill project to include all minerals, setting the stage for a maiden drilling campaign in 2026 amid soaring yttrium prices.